215 Autism Markers & New Data Targets – Woeller-2

Autism Spectrum Markers: Expert Opinion On Biomedical Testing For ASDYou can have data without information, but you cannot have information without data.~ Daniel Keys Moran

Dr. Kurt N. Woeller became a biomedical autism specialist many years ago in 1998. An original Defeat Autism Now! (DAN!) Referral physician, he has years of experience in researching and implementing advanced biomedical interventions based upon autism spectrum markers from laboratory testing, for individuals suffering from autism spectrum challenges. He now works as the Autism Outreach Clinical Director for Great Plains Laboratories in addition to his interesting treatment and training practice linked next.

His extensive network of exceedingly helpful educational websites, books and webinars provide parents of individuals on the autism-spectrum, as well as physicians and other healthcare providers treating autism, access to an abundance of valuable information regarding the latest biomedical intervention systems.

Ed. Note: This Dr. Woeller interview is the second in this CBJ Autism Series, and republished from our earlier CBJ interview because of its essential value to both parents and professionals on many levels.

*Photo by Mark Tegethoff on Unsplash

Connections To Understand More About Autism Spectrum Markers

Professionals: To engage in direct interaction with Dr. Woeller you can subscribe to his biomedical autism training website at AutismRecoverySystem.com - an in-depth resource for both professionals and parents.

Public: You must participate in Dr. Woeller's other recent mentoring program, The Autism Global Summit - AGS - an outstanding group of professionals who team up to discuss biomedical applications and informed, practical understandings in everyday life for those suffering from Spectrum Disorders. Thanks, Dr. Woeller for inviting me as a Guest Speaker on AGS to discuss the almost taboo subject of psychiatric medications for Executive Function and ASD issues for your interested audience at the Autism Global Summit.

My uncomplicated point at AGS: If we aim to treat the entire Spectrum, then specific medications can help - if used correctly. The reason for so much medical treatment failure with those trying to treat ASD issues with psych medications is at once simple and complex: overt denial of underlying biomedical impediments that interfere both with meds and supplements. Consider, for example, the pervasive national denial with ubiquitous IgG issues.

Because so much of ASD often does involve Executive Function why not put that subject on the table? At AGS I discussed the most pervasive problem in psychiatric diagnosis and treatment today: Cognition, Executive Function Diagnosis, and Medical Treatment including Biomedical Interventions. Dysregulation of Executive Function with Cognitive Desynchronization does exist beyond the labels and appearances of ADHD. Due to the metabolic challenges with ASD, one must understand the medical parameters and options to intervene as correctly and comprehensively as...